Congenital hypothyroidism remains one of the most common preventable causes of mental retardation among children. Screening for congenital hypothyroidism remains one of the most cost-effective tools to prevent mental retardation in the population. Umbilical cord blood thyroid-stimulating hormone (TSH) levels remain an attractive and a practical step for screening for congenital hypothyroidism.
Introduction
Congenital hypothyroidism is one of the most common preventable causes of mental retardation in the country. It has an incidence of 1 in 4000 births in various neonatal screening programs. 1 Screening for congenital hypothyroidism remains are widespread in developed countries. However, unfortunately, such a nationwide program is nonexistent in are widespread in developed countries. However, unfortunately, such a nationwide program is nonexistent in our country. Ideally, universal screening at 3 to 4 days should be done for the detection of congenital hypothyroidism. However, with babies being discharged early, the absence of a supportive follow-up system has led cord blood TSH levels being used as a screening marker for the detection of congenital hypothyroidism. 2 Various Asian countries have started using cord blood samples for the screening of congenital hypothyroidism. [3] [4] [5] [6] Very few studies on cord blood TSH values are available in the Indian literature. 7 This study was conducted to find out normative values of TSH in cord blood samples and to use the cord blood TSH value as a screening marker for congenital hypothyroidism.
Material and Methods
The study was carried out from October 2013 to October 2017 in a private medical college in India. All consecutive deliveries conducted during this period were part of the study. All the deliveries were attended by either of the two authors.
Blood samples were collected in a sterile container drawn from 15 to 20 cm length of the umbilical cord incised during the time of birth of a baby. The sample obtained was a mixed one that contained blood from both the umbilical artery and umbilical vein. Babies who were born premature, weighed less than 2.5 kg at birth, required resuscitation, and whose mothers were on thyroid medications were excluded from the study.
Detailed antenatal history, parity, medical history, thyroid status, and community were recorded on a predesigned performa. Details of the baby were recorded on a separate performa. TSH was estimated within 24 hours by chemiluminscence immunoassay (a kit supplied by Roche, Basel, Switzerland). Cord blood samples of 1824 neonates were subjected to TSH estimation. A total of 1824 neonates formed the study group. All those neonates who had a cord blood TSH value >20 mIu/ ml were called back on day 7 of life and a full thyroid profile including TSH, T3,T4, fT3, fT4 was measured.
Results
Cord blood samples of 1824 neonates were tested for TSH. The male to female ratio was 979:845 = 1.15:1. The birth weights ranged between 2.5 and 4.5 kg with an average birth weight of 2.811 kg ( Table 1 ). The mean (SD) TSH value was 7.725 (8.99) among the study group. Table 2 depicts the TSH values of the entire cohort. TSH values of the cohort ranged between 1.2 and 100 mIU/ml. TSH values corresponding to 3rd, 10th, 25th, 50th, 90th, 95th, and 97th percentile were 2.32, 3.03, 4.05, 5.67, 7.5, 12, 20.63, and 30.88 respectively. Among the 88 patients recalled for repeat sampling, 80 turned up and 8 were lost to follow up. Finally, 1 neonate proved to be hypothyroid on repeat workup. The cord blood TSH value in the baby who eventually turned out to be hypothyroid was 100 mIU/ml. 
Discussion
Screening for congenital hypothyroidism is the need for the hour. Unfortunately, it has not been implemented in India on a nationwide basis because of the lack of available facilities and awareness among treating physicians, cost, and early discharge of neonates on account of overburden in the government setups. The use of cord blood TSH as a screening tool for congenital hypothyroidism remains a practical option because of its ease of availability, simplicity, and accessibility. Studies across the world have shown that cord blood remains a good sampling technique for the screening of congenital hypothyroidism. Our results show that 10% samples had a cord blood TSH value >10mIu/ml, which is slightly higher as compared with that reported by Manglik et al. 2 and Mekennen et al. 8 Our mean TSH value was 7.725 mIU/L, which is quite comparable to other studies. Our recall rate for repeat testing was 4.8%, which is somewhat higher as compared with 2.27% reported by Wu et al. 6 who had a large cohort of 11 000 neonates. There is a wide variation in the normal cord blood TSH values that can vary from 1 to 38.9 mIU/L. 8 We have used a cutoff value of 20 mIU/L, which has also been used in studies across the world. Had we used a cutoff value of 30mIU/L, our recall rate would have fallen to 3%; on further increasing the cutoff value to 40mIU/l, the recall rate would have fallen to 2%. Considering our annual birth rate of 20 million babies, a recall rate of 4.8% almost 960 000 babies would need to be called back for a repeat thyroid profile. It would be a herculean task in our country. Higher cutoff values of TSH for recall would lead to lesser babies being called for repeat testing, thereby decreasing the economic and logistic burden on the existing health care facilities.
We had 1 baby with congenital hypothyroidism in a cohort of 1824, thereby giving us an incidence of 1 in 1824. Various studies from across India have reported the incidence of congenital hypothyroidism as varied as between 1 in 248 and 1 in 1700. 9, 10 Geographic and ethnic differences are responsible for this wide variation in the incidence of congenital hypothyroidism, and a cohort size of 1824 samples is too less to assess the incidence.
Our figures have shown a comparable trend with the normative data for cord blood TSH values as reported by various workers across the globe.
The biggest drawback of our study is the small sample size. Large population-based studies are required to gauge and calculate the incidence of congenital hypothyroidism in our country.
Conclusion
To conclude, we can safely use a cutoff of the cord blood TSH value >20 mIU/L for the purpose of the screening of congenital hypothyroidism. For logistic angles, a higher cutoff >30mIU/L can be used. Large population-based studies are required to establish normative values for cord blood TSH in our country.
